AstraZeneca PLC is 37.2x more valuable than Abivax S.A. by market capitalization ($286.27 B vs $7.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABVX | AZN |
|---|---|---|
| Market cap | $7.70 B | $286.27 B |
| US-listed rank | #1093 | #45 |
| SEC filings | 92 | 1,004 |
AstraZeneca PLC is 37.2x more valuable than Abivax S.A. by market capitalization ($286.27 B vs $7.70 B).
Full pages: Abivax S.A. and AstraZeneca PLC, or browse the full rankings.